+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Intelligence in Pharmaceutical Market - Global Forecast 2026-2032- Product Image
Artificial Intelligence in Pharmaceutical Market - Global Forecast 2026-2032- Product Image
New

Artificial Intelligence in Pharmaceutical Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 195 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5896366
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The artificial intelligence in pharmaceutical market is transforming industry operations as decision-makers embrace advanced analytics and machine learning to drive innovation, efficiency, and compliance in a growingly complex and competitive landscape.

Market Snapshot: Artificial Intelligence in Pharmaceutical Market

The artificial intelligence in pharmaceutical market expanded from USD 20.08 billion in 2025 to USD 25.54 billion in 2026. Projections indicate continued rapid growth at a compound annual growth rate (CAGR) of 27.68%, with the market forecast to reach USD 111.13 billion by 2032. This expansion reflects sustained digital transformation across discovery, clinical development, and commercial operations, supported by ongoing investment from pharmaceutical and biotechnology companies seeking to optimize research and development pipelines, navigate regulatory landscapes, and streamline operational performance.

Scope & Segmentation

  • Component: Spans managed and professional services for deployment, integration, and lifecycle management, as well as software solutions supporting clinical trial management platforms, diagnostic applications, drug discovery suites, regulatory compliance tools, and supply chain management systems.
  • Technology: Incorporates computer vision for imaging and object detection, deep learning frameworks (including convolutional and recurrent neural networks and transformers), machine learning approaches (such as supervised, unsupervised, and reinforcement learning), natural language processing for text and speech analysis, and robotic process automation to streamline routine tasks.
  • Therapeutic Focus: Includes cardiovascular, immunology, infectious diseases, metabolic diseases, neurology, oncology, and respiratory applications, each influencing the selection of AI methodologies and validation strategies due to unique clinical and regulatory demands.
  • Application: Covers clinical trials management, patient recruitment, predictive analytics, drug discovery (from design and validation to lead optimization and target selection), personalized healthcare (including biomarker discovery and genomic profiling), and supply chain management such as demand forecasting and logistics optimization.
  • Deployment: Addresses cloud-based, on-premises, and hybrid models, offering solutions tailored to diverse scalability, security, and compliance needs in varying operational environments.
  • End User: Serves pharmaceutical and biotechnology firms, contract research organizations, and academic and research institutions, each with distinct risk profiles and preferences for internal or collaborative innovation.
  • Region: Focuses on the Americas, Europe, Middle East & Africa, and Asia-Pacific, with variations in regulatory frameworks, data privacy requirements, and availability of skilled talent shaping regional adoption and implementation strategies.

Key Takeaways for Leaders

  • Strategic adoption of artificial intelligence is reshaping pharmaceutical research and development, offering scalable options to address intricate data landscapes and resource constraints.
  • Integrating advanced machine learning into clinical workflows requires multidisciplinary talent, robust governance, and trusted partnerships to achieve compliance and innovation simultaneously.
  • The industry trend moves from experimental applications to the operationalization of AI, with significant investments in model governance, data lineage, and reproducibility to align with evolving regulatory expectations.
  • Flexible operational models, including cloud-native solutions and managed services, improve resilience and adaptability as procurement and technology strategies mature within enterprises.
  • Differences in regional regulatory scrutiny, data infrastructure, and privacy standards require tailored deployment and validation efforts, ensuring that adoption aligns with local compliance and operational contexts.
  • Organizations realizing sustained competitive advantage align AI technology choices, deployment approaches, and external support with their specific therapeutic concentrations and internal structures.

Tariff Impact on AI-Enabled Pharmaceutical Operations

Tariff regulations introduced in 2025 presented challenges for pharmaceutical organizations operating global supply chains, especially those dependent on specialized hardware and cross-border collaborations. Procurement teams have responded by diversifying supplier bases, renegotiating contracts, and balancing the adoption of cloud-based versus on-premises solutions. This adaptive approach supports the continued delivery of critical capabilities while navigating new pressures on costs and project timelines. As a result, resilient sourcing and comprehensive risk management have become central to the deployment and scale of AI solutions within pharmaceutical operations.

Methodology & Data Sources

This market assessment synthesizes findings from structured interviews with leaders in the pharmaceutical and biotechnology sectors, academic researchers, and technology providers. Supplemented by analysis of scientific literature, regulatory documentation, and public disclosures, this methodology ensures the validity and transparency of recommendations through expert validation and real-world case study review.

Why This Report Matters

  • Equips senior decision-makers with guidance for responding to rapid regulatory, technological, and operational changes in pharmaceutical AI adoption.
  • Supports informed investment and procurement by clarifying best practices and highlighting evolving strategies within the marketplace.
  • Enables organizations to mitigate risk as they scale AI programs, with insight tailored to therapeutic areas, regional differences, and unique organizational needs.

Conclusion

Artificial intelligence is now a fundamental component of pharmaceutical strategy, enabling businesses to enhance agility, strengthen validation, and improve operational efficiency. Sustainable advantage is achieved when technology, governance, and deployment are closely aligned with market realities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Artificial Intelligence in Pharmaceutical Market, by Component
8.1. Services
8.1.1. Managed Services
8.1.2. Professional Services
8.2. Software
8.2.1. Clinical Trial Management Software
8.2.2. Diagnostic Software
8.2.3. Drug Discovery Platforms
8.2.4. Regulatory Compliance Tools
8.2.5. Supply Chain Management Software
9. Artificial Intelligence in Pharmaceutical Market, by Technology
9.1. Computer Vision
9.1.1. Image Segmentation
9.1.2. Medical Imaging
9.1.3. Object Detection
9.2. Deep Learning
9.2.1. Convolutional Neural Networks
9.2.2. Generative Adversarial Networks
9.2.3. Recurrent Neural Networks
9.2.4. Transformers
9.3. Machine Learning
9.3.1. Reinforcement Learning
9.3.2. Supervised Learning
9.3.3. Unsupervised Learning
9.4. Natural Language Processing
9.4.1. Sentiment Analysis
9.4.2. Speech Recognition
9.4.3. Text Mining
9.5. Robotic Process Automation
10. Artificial Intelligence in Pharmaceutical Market, by Therapeutic Area
10.1. Cardiovascular Diseases
10.2. Immunology
10.3. Infectious Diseases
10.4. Metabolic Diseases
10.5. Neurology
10.6. Oncology
10.7. Respiratory Diseases
11. Artificial Intelligence in Pharmaceutical Market, by Applications
11.1. Clinical Trials
11.1.1. Clinical Data Management
11.1.2. Patient Recruitment
11.1.3. Predictive Analytics
11.1.4. Risk-Based Monitoring
11.2. Drug Discovery
11.2.1. Drug Design
11.2.2. End-Model Validation
11.2.3. Lead Optimization
11.2.4. Target Selection
11.3. Personalized Healthcare
11.3.1. Biomarker Discovery
11.3.2. Genomic Profiling
11.3.3. Precision Medicine Development
11.4. Supply Chain Management
11.4.1. Demand Forecasting
11.4.2. Inventory Management
11.4.3. Logistics Optimization
12. Artificial Intelligence in Pharmaceutical Market, by Deployment Type
12.1. Cloud-Based
12.2. On-Premises
13. Artificial Intelligence in Pharmaceutical Market, by End User
13.1. Academic and Research Institutions
13.2. Contract Research Organizations (CROs)
13.3. Pharmaceutical & Biotechnology Companies
14. Artificial Intelligence in Pharmaceutical Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Artificial Intelligence in Pharmaceutical Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Artificial Intelligence in Pharmaceutical Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Artificial Intelligence in Pharmaceutical Market
18. China Artificial Intelligence in Pharmaceutical Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. AiCure, LLC
19.6. Aspen Technology Inc.
19.7. Atomwise Inc.
19.8. BenevolentAI SA
19.9. BioSymetrics Inc.
19.10. BPGbio Inc.
19.11. Butterfly Network, Inc.
19.12. Cloud Pharmaceuticals, Inc.
19.13. Cyclica by Recursion Pharmaceuticals, Inc.
19.14. Deargen Inc.
19.15. Deep Genomics Incorporated
19.16. Deloitte Touche Tohmatsu Limited
19.17. Euretos Services BV
19.18. Exscientia PLC
19.19. Insilico Medicine
19.20. Intel Corporation
19.21. International Business Machines Corporation
19.22. InveniAI LLC
19.23. Isomorphic Labs Limited
19.24. Microsoft Corporation
19.25. Novo Nordisk A/S
19.26. NVIDIA Corporation
19.27. Oracle Corporation
19.28. SANOFI WINTHROP INDUSTRIE
19.29. Turbine Ltd.
19.30. Viseven Europe OU
19.31. XtalPi Inc.
List of Figures
FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MANAGED SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MANAGED SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PROFESSIONAL SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PROFESSIONAL SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PROFESSIONAL SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY REGULATORY COMPLIANCE TOOLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY REGULATORY COMPLIANCE TOOLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY REGULATORY COMPLIANCE TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPUTER VISION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPUTER VISION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPUTER VISION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY IMAGE SEGMENTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY IMAGE SEGMENTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY IMAGE SEGMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MEDICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MEDICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MEDICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OBJECT DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OBJECT DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OBJECT DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY GENERATIVE ADVERSARIAL NETWORKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY GENERATIVE ADVERSARIAL NETWORKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY GENERATIVE ADVERSARIAL NETWORKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TRANSFORMERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TRANSFORMERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TRANSFORMERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY REINFORCEMENT LEARNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY REINFORCEMENT LEARNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY REINFORCEMENT LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPERVISED LEARNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPERVISED LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY UNSUPERVISED LEARNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY UNSUPERVISED LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SENTIMENT ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SENTIMENT ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SENTIMENT ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SPEECH RECOGNITION, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SPEECH RECOGNITION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SPEECH RECOGNITION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TEXT MINING, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TEXT MINING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TEXT MINING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY ROBOTIC PROCESS AUTOMATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY ROBOTIC PROCESS AUTOMATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY ROBOTIC PROCESS AUTOMATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY METABOLIC DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY METABOLIC DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RESPIRATORY DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RESPIRATORY DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL DATA MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL DATA MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL DATA MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PATIENT RECRUITMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PATIENT RECRUITMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PATIENT RECRUITMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PREDICTIVE ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PREDICTIVE ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RISK-BASED MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RISK-BASED MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RISK-BASED MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DESIGN, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DESIGN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DESIGN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-MODEL VALIDATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-MODEL VALIDATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-MODEL VALIDATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY LEAD OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TARGET SELECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TARGET SELECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TARGET SELECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY GENOMIC PROFILING, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY GENOMIC PROFILING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY GENOMIC PROFILING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PRECISION MEDICINE DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PRECISION MEDICINE DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PRECISION MEDICINE DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEMAND FORECASTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEMAND FORECASTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEMAND FORECASTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY INVENTORY MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY INVENTORY MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY INVENTORY MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY LOGISTICS OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY LOGISTICS OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY LOGISTICS OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT TYPE, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY ON-PREMISES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY ON-PREMISES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY GROUP, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 190. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 191. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 192. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 193. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 194. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 195. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPUTER VISION, 2018-2032 (USD MILLION)
TABLE 196. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
TABLE 197. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
TABLE 198. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2032 (USD MILLION)
TABLE 199. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 200. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 201. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 202. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 203. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, 2018-2032 (USD MILLION)
TABLE 204. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 205. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT TYPE, 2018-2032 (USD MILLION)
TABLE 206. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 209. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 210. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 211. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 212. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPUTER VISION, 2018-2032 (USD MILLION)
TABLE 213. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
TABLE 214. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
TABLE 215. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2032 (USD MILLION)
TABLE 216. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 217. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 218. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 219. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 220. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, 2018-2032 (USD MILLION)
TABLE 221. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 222. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT TYPE, 2018-2032 (USD MILLION)
TABLE 223. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 225. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 226. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 227. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 228. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 229. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPUTER VISION, 2018-2032 (USD MILLION)
TABLE 230. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
TABLE 231. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
TABLE 232. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2032 (USD MILLION)
TABLE 233. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 234. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 235. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 236. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 237. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED HEALTHCARE, 2018-2032 (USD MILLION)
TABLE 238. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPLY CHAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 239. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT TYPE, 2018-2032 (USD MILLION)
TABLE 240. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPUTER VISION, 2018-2032 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2032 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, 2018-2032 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PERSONALIZED

Companies Mentioned

The key companies profiled in this Artificial Intelligence in Pharmaceutical market report include:
  • AiCure, LLC
  • Aspen Technology Inc.
  • Atomwise Inc.
  • BenevolentAI SA
  • BioSymetrics Inc.
  • BPGbio Inc.
  • Butterfly Network, Inc.
  • Cloud Pharmaceuticals, Inc.
  • Cyclica by Recursion Pharmaceuticals, Inc.
  • Deargen Inc.
  • Deep Genomics Incorporated
  • Deloitte Touche Tohmatsu Limited
  • Euretos Services BV
  • Exscientia PLC
  • Insilico Medicine
  • Intel Corporation
  • International Business Machines Corporation
  • InveniAI LLC
  • Isomorphic Labs Limited
  • Microsoft Corporation
  • Novo Nordisk A/S
  • NVIDIA Corporation
  • Oracle Corporation
  • SANOFI WINTHROP INDUSTRIE
  • Turbine Ltd.
  • Viseven Europe OU
  • XtalPi Inc.

Table Information

Report AttributeDetails
No. of Pages195
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 25.54 Billion
Forecasted Market Value ( USD ) by 2032 $ 111.13 Billion
Compound Annual Growth Rate27.6%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Artificial Intelligence Market Global Report by Solution, Technology, End-User, Countries and Company Analysis 2025-2033 - Product Image

Artificial Intelligence Market Global Report by Solution, Technology, End-User, Countries and Company Analysis 2025-2033

  • Report
  • 250 Pages
  • Global
From
United States Artificial Intelligence Market Report and Forecast 2025-2034 - Product Image

United States Artificial Intelligence Market Report and Forecast 2025-2034

  • Report
  • 135 Pages
  • United States
From
North America Artificial Intelligence Market, By Country, Competition, Forecast, and Opportunities, 2019-2029F - Product Image

North America Artificial Intelligence Market, By Country, Competition, Forecast, and Opportunities, 2019-2029F

  • Report
  • 132 Pages
  • North America
From
Artificial Intelligence (AI) and the Metaverse: Intellectual Property (IP) and Standards and Policies Training Course (May 20, 2026) - Product Image

Artificial Intelligence (AI) and the Metaverse: Intellectual Property (IP) and Standards and Policies Training Course (May 20, 2026)

  • Training
  • 1 Day
  • Global
Artificial Intelligence in Biomedical Market - Global Forecast 2026-2032 - Product Image

Artificial Intelligence in Biomedical Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.